1. Home
  2. MRTN vs PHAT Comparison

MRTN vs PHAT Comparison

Compare MRTN & PHAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Marten Transport Ltd.

MRTN

Marten Transport Ltd.

HOLD

Current Price

$12.64

Market Cap

850.3M

Sector

Industrials

ML Signal

HOLD

Logo Phathom Pharmaceuticals Inc.

PHAT

Phathom Pharmaceuticals Inc.

HOLD

Current Price

$14.81

Market Cap

942.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MRTN
PHAT
Founded
1946
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Trucking Freight/Courier Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
850.3M
942.6M
IPO Year
1986
2019

Fundamental Metrics

Financial Performance
Metric
MRTN
PHAT
Price
$12.64
$14.81
Analyst Decision
Buy
Strong Buy
Analyst Count
1
6
Target Price
$19.00
$17.33
AVG Volume (30 Days)
932.4K
1.4M
Earning Date
01-23-2026
03-05-2026
Dividend Yield
1.94%
N/A
EPS Growth
N/A
N/A
EPS
0.24
N/A
Revenue
$903,976,000.00
$147,190,000.00
Revenue This Year
N/A
$220.82
Revenue Next Year
$0.24
$82.87
P/E Ratio
$52.14
N/A
Revenue Growth
N/A
460.30
52 Week Low
$9.35
$2.21
52 Week High
$16.95
$18.31

Technical Indicators

Market Signals
Indicator
MRTN
PHAT
Relative Strength Index (RSI) 66.51 44.76
Support Level $12.33 $13.79
Resistance Level $13.00 $16.12
Average True Range (ATR) 0.36 0.90
MACD 0.02 -0.29
Stochastic Oscillator 80.64 24.34

Price Performance

Historical Comparison
MRTN
PHAT

About MRTN Marten Transport Ltd.

Marten Transport Ltd is a temperature-sensitive truckload carrier in the United States. The company specializes in transporting and distributing food and other consumer packaged goods that require a temperature-controlled or insulated environment. It operates through four segments: Truckload, Dedicated, Intermodal, and Brokerage, generating the majority of its revenue from the Truckload segment. The Truckload segment offers a mix of regional short-haul and medium- to long-haul full-load transportation services.

About PHAT Phathom Pharmaceuticals Inc.

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

Share on Social Networks: